Cohort study on osteoporosis in China
Official title: Multicenter Cohort Study on Osteoporosis in the Middle-aged and Elderly People in Shanghai, China
Run by Shanghai University of Traditional Chinese Medicine · NCT02958020 · Data updated 2026-11-12
This study is trying to understand osteoporosis in middle-aged and older people in China by looking at their health habits and history through questionnaires and blood tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 79 Years |
| Sex | All |
| Enrollment | 50000 (estimated) |
| Sponsor | Shanghai University of Traditional Chinese Medicine Academic / other |
| Locations | 12 sites (Shenzhen, Guangdong and 11 other locations) |
| Status | Recruiting |
| Started | November 2016 |
| Main results expected | October 2026 |
| Study ends | October 2028 |
| Registry record updated | September 23, 2021 |
| Trial ID | NCT02958020 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are middle-aged and elderly permanent residents of China, specifically women aged 45 to 79 and men aged 50 to 79.
✕Probably not a fit
Patients with severe mental or physical diseases, acute infectious diseases, or those who are lactating or pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter cohort study investigates osteoporosis among middle-aged and elderly residents across nine cities in China. It aims to enroll at least 3000 participants, focusing on demographic factors, lifestyle habits, and health history to assess osteoporosis risk. Participants will complete questionnaires and undergo blood tests to evaluate their health status and risk factors related to osteoporosis. The study seeks to gather comprehensive data to better understand osteoporosis in the Chinese population.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into osteoporosis risk factors and improve prevention strategies for patients.
How similar studies have gone: Other studies have shown success in similar cohort approaches to understanding osteoporosis, indicating that this methodology is well-established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * permanent residents * women aged from 45 to 79, and men aged from 50 to 79 Exclusion Criteria: * severe mental diseases, physical diseases or acute infectious diseases who could not cooperate with the survey. * lactating or pregnant women.
Where it's running
-
Shenzhen Pingle Orthopedic Hospital
Shenzhen, Guangdong, China Recruiting -
First People's Hospital of Nankang District, Ganzhou City
Ganzhou, Jiangxi, China Recruiting -
Shandong Provincial Hospital of Traditional Chinese Medicine
Jinan, Shandong, China Recruiting -
Dongzhimen Hospital, Beijing
Beijing, China Recruiting -
Wangjing Hospital, China Academy of Chinese Medical Sciences
Beijing, China Recruiting -
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Changchun, China Recruiting
Show 6 more locations
-
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou, China Recruiting -
Guangzhou Kingmed Diagnostics Co., Ltd.
Guangzhou, China Recruiting -
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Guangzhou, China Recruiting -
Gansu Provincial Hospital of Traditional Chinese Medicine
Lanzhou, China Recruiting -
Longhua Hospital, Shanghai University of TCM
Shanghai, China Recruiting -
Yunnan Provincial Hospital of Traditional Chinese Medicine
Kunming, Yunnan, China Not yet recruiting
Study contacts
- Principal investigator: Yongjun Wang — Shanhgai University of TCM
- Study coordinator: Yongjun Wang
- Email: yjwang88@hotmail.com
- Phone: 86-21-64385700
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Can a blood marker called lumican reveal hidden fragility in postmenopausal osteoporosis
This study tests whether serum lumican levels can help identify hidden fragility risk in postmenopausal women beyond what bone density shows.
-
Functional Muscle-Bone Incongruity Index: A look at muscle strength and bone health in adults
This observational study tests a composite FKUI score using handgrip strength and hip/spine bone density to see if it better reflects musculoskeletal health than each measure alone in adults undergoing routine DXA.
-
Vessel-X Bone Filling Container System for Vertebral Augmentation
A new minimally invasive vertebral augmentation approach tests the Vessel-X device to see if it safely improves pain and function in people with osteoporotic vertebral compression fractures.
-
Proximal Humerus Cortical Thickness in Post-Stroke Paresis
This study tests whether measurements of the outer bone thickness of the upper arm (the humerus) on the paretic side after a stroke reflect regional bone loss and how well they agree with standard bone density tests.
-
People with Osteoporosis: See if Walk-BEST Gait Program Helps You Walk Safer
This pilot study tests whether older adults with osteoporosis can use the Walk-BEST gait training with a wearable sensor to walk more safely and reduce fall risk.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.